Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Clinical Therapeutics | journal | 1.190 Q1 | 150 | 249 | 705 | 9196 | 2052 | 613 | 2.75 | 36.93 | 36.83 | |
52 | Antimicrobial Resistance and Infection Control | journal | 1.182 Q1 | 66 | 56 | 127 | 1944 | 414 | 119 | 3.04 | 34.71 | 46.93 | |
53 | Biologics: Targets and Therapy | journal | 1.133 Q1 | 47 | 18 | 65 | 1047 | 276 | 63 | 3.76 | 58.17 | 43.75 | |
54 | Drug Metabolism Reviews | journal | 1.129 Q1 | 108 | 33 | 98 | 4523 | 401 | 94 | 4.15 | 137.06 | 41.58 | |
55 | Pharmacotherapy | journal | 1.128 Q1 | 126 | 153 | 488 | 4690 | 1588 | 452 | 3.24 | 30.65 | 48.21 | |
56 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.127 Q1 | 57 | 59 | 184 | 2833 | 510 | 179 | 2.95 | 48.02 | 24.87 | |
57 | Journal of Clinical Psychopharmacology | journal | 1.122 Q1 | 130 | 177 | 580 | 4893 | 1078 | 297 | 1.62 | 27.64 | 40.40 | |
58 | Journal of Addiction Medicine | journal | 1.113 Q1 | 58 | 80 | 232 | 2340 | 508 | 216 | 2.15 | 29.25 | 45.25 | |
59 | Pharmaceutical Research | journal | 1.112 Q1 | 229 | 241 | 853 | 11327 | 3303 | 843 | 3.57 | 47.00 | 35.83 | |
60 | Expert Review of Neurotherapeutics | journal | 1.102 Q1 | 98 | 141 | 411 | 11575 | 1262 | 388 | 3.15 | 82.09 | 31.58 | |
61 | European Journal of Clinical Pharmacology | journal | 1.098 Q1 | 123 | 179 | 633 | 5787 | 1828 | 563 | 2.95 | 32.33 | 41.98 | |
62 | International Clinical Psychopharmacology | journal | 1.097 Q1 | 98 | 46 | 144 | 1698 | 457 | 142 | 3.51 | 36.91 | 37.37 | |
63 | Cardiovascular Therapeutics | journal | 1.095 Q1 | 54 | 58 | 168 | 2165 | 424 | 161 | 2.53 | 37.33 | 31.96 | |
64 | Targeted Oncology | journal | 1.081 Q1 | 59 | 75 | 128 | 3460 | 407 | 124 | 3.04 | 46.13 | 38.46 | |
65 | PPAR Research | journal | 1.079 Q2 | 59 | 31 | 88 | 2200 | 248 | 85 | 2.87 | 70.97 | 46.25 | |
66 | Therapeutic Advances in Infectious Disease | journal | 1.074 Q2 | 29 | 13 | 26 | 750 | 92 | 23 | 2.67 | 57.69 | 31.91 | |
67 | Cardiovascular Drugs and Therapy | journal | 1.067 Q2 | 79 | 66 | 207 | 3398 | 560 | 170 | 2.54 | 51.48 | 35.25 | |
68 | Annals of Pharmacotherapy | journal | 1.049 Q2 | 122 | 151 | 666 | 3891 | 1810 | 573 | 2.77 | 25.77 | 53.97 | |
69 | Journal of Supportive Oncology | journal | 1.047 Q2 | 65 | 0 | 27 | 0 | 56 | 23 | 0.00 | 0.00 | 0.00 | |
70 | Journal of Clinical Pharmacology | journal | 1.046 Q2 | 130 | 195 | 519 | 7813 | 1484 | 491 | 2.76 | 40.07 | 38.10 | |
71 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.041 Q2 | 52 | 34 | 73 | 3074 | 256 | 69 | 3.29 | 90.41 | 32.88 | |
72 | Expert Review of Clinical Pharmacology | journal | 1.040 Q2 | 60 | 156 | 228 | 11087 | 661 | 208 | 2.84 | 71.07 | 39.29 | |
73 | BioDrugs | journal | 1.035 Q2 | 79 | 48 | 139 | 2995 | 476 | 131 | 3.18 | 62.40 | 45.00 | |
74 | Human Psychopharmacology | journal | 1.018 Q2 | 86 | 46 | 203 | 2208 | 570 | 201 | 2.58 | 48.00 | 42.64 | |
75 | Expert Opinion on Pharmacotherapy | journal | 1.014 Q2 | 93 | 238 | 734 | 17781 | 2325 | 715 | 3.40 | 74.71 | 38.54 | |
76 | AIDS Research and Therapy | journal | 1.010 Q2 | 49 | 41 | 115 | 1960 | 262 | 113 | 1.89 | 47.80 | 39.09 | |
77 | Pharmaceutical Statistics | journal | 1.004 Q2 | 46 | 55 | 152 | 1667 | 195 | 145 | 1.22 | 30.31 | 23.57 | |
78 | OncoTargets and Therapy | journal | 0.990 Q2 | 86 | 768 | 890 | 29254 | 2692 | 881 | 2.86 | 38.09 | 38.34 | |
79 | Paediatric Drugs | journal | 0.986 Q2 | 70 | 44 | 147 | 2433 | 407 | 139 | 2.56 | 55.30 | 55.25 | |
80 | Advances in Therapy | journal | 0.974 Q2 | 83 | 135 | 251 | 6279 | 774 | 245 | 3.02 | 46.51 | 31.78 | |
81 | Therapeutic Advances in Respiratory Disease | journal | 0.955 Q2 | 50 | 48 | 82 | 2539 | 230 | 74 | 2.98 | 52.90 | 31.09 | |
82 | Clinical Pharmacology: Advances and Applications | journal | 0.941 Q2 | 34 | 19 | 62 | 1003 | 183 | 58 | 3.24 | 52.79 | 26.14 | |
83 | Inflammopharmacology | journal | 0.941 Q2 | 68 | 43 | 109 | 1799 | 335 | 104 | 2.96 | 41.84 | 31.82 | |
84 | BMC pharmacology & toxicology | journal | 0.940 Q2 | 43 | 62 | 180 | 2499 | 525 | 177 | 2.81 | 40.31 | 37.34 | |
85 | Infection and Chemotherapy | journal | 0.928 Q2 | 38 | 59 | 148 | 1212 | 309 | 132 | 1.75 | 20.54 | 40.47 | |
86 | American Journal of Cardiovascular Drugs | journal | 0.927 Q2 | 60 | 44 | 129 | 2322 | 358 | 121 | 2.98 | 52.77 | 25.58 | |
87 | Vascular Health and Risk Management | journal | 0.912 Q2 | 82 | 52 | 213 | 2739 | 647 | 206 | 3.11 | 52.67 | 30.85 | |
88 | HIV Clinical Trials | journal | 0.899 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
89 | Journal of Child and Adolescent Psychopharmacology | journal | 0.897 Q2 | 92 | 164 | 357 | 5133 | 679 | 245 | 1.83 | 31.30 | 46.86 | |
90 | Clinical Psychopharmacology and Neuroscience | journal | 0.893 Q2 | 42 | 67 | 119 | 2530 | 259 | 111 | 2.01 | 37.76 | 29.39 | |
91 | Fundamental and Clinical Pharmacology | journal | 0.840 Q2 | 85 | 64 | 212 | 2749 | 548 | 211 | 2.45 | 42.95 | 46.58 | |
92 | Pulmonary Pharmacology and Therapeutics | journal | 0.816 Q2 | 81 | 63 | 296 | 3045 | 803 | 270 | 2.63 | 48.33 | 38.52 | |
93 | Synergy | journal | 0.813 Q2 | 15 | 4 | 22 | 79 | 32 | 20 | 1.45 | 19.75 | 46.15 | |
94 | Drug Target Insights | journal | 0.790 Q2 | 16 | 8 | 18 | 333 | 58 | 18 | 1.83 | 41.63 | 25.53 | |
95 | Anti-Cancer Drugs | journal | 0.780 Q2 | 102 | 159 | 396 | 5579 | 967 | 390 | 2.52 | 35.09 | 37.83 | |
96 | Cardiology | journal | 0.777 Q2 | 72 | 126 | 426 | 2803 | 576 | 301 | 1.28 | 22.25 | 28.32 | |
97 | Current Therapeutic Research | journal | 0.776 Q2 | 46 | 7 | 94 | 143 | 287 | 90 | 3.15 | 20.43 | 15.38 | |
98 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | journal | 0.771 Q2 | 81 | 51 | 152 | 2228 | 391 | 148 | 2.57 | 43.69 | 36.43 | |
99 | Therapeutics and Clinical Risk Management | journal | 0.765 Q2 | 70 | 211 | 378 | 8586 | 940 | 365 | 2.55 | 40.69 | 34.84 | |
100 | Expert Opinion on Emerging Drugs | journal | 0.762 Q2 | 54 | 38 | 131 | 3609 | 377 | 127 | 3.21 | 94.97 | 34.85 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®